Put Warnings About Liver Damage With Hep C Meds Into Perspective
You'll hear about a link between hepatitis C meds and liver damage...especially in patients who also have hepatitis B.
FDA now requires a boxed warning about the risk of hepatitis B reactivation with newer hep C meds...Epclusa, Harvoni, Zepatier, etc.
And a recent report from Institute for Safe Medication Practices warns about rare cases of liver injury and failure tied to these meds. Viekira Pak and Technivie already have warnings in their labeling about liver injury, mostly in patients with advanced liver disease.